Heart Conduction and ECG Basics
25 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the mechanism of action of digoxin?

  • Blocks both activated and inactivated L-type calcium channels
  • Inhibits Ca2+ channels
  • Activates inward rectifier K+ current
  • Inhibits Na+/K+-ATPase (correct)
  • Which antiarrhythmic agent is the drug of choice for paroxysmal supraventricular tachycardia?

  • Magnesium
  • Verapamil
  • Diltiazem
  • Adenosine (correct)
  • What effect does verapamil have on the heart?

  • Increases blood pressure
  • Increases cardiac contractility
  • Slows SA node automaticity (correct)
  • Enhances AV nodal conduction velocity
  • What is a possible toxicity associated with potassium administration?

    <p>Reentrant arrhythmias</p> Signup and view all the answers

    What clinical condition is magnesium commonly used to treat?

    <p>Torsade de pointes</p> Signup and view all the answers

    What is characterized by the absence of visible P waves and irregular R-R intervals?

    <p>Atrial Fibrillation</p> Signup and view all the answers

    What condition results from the interaction of three specific criteria involving conduction and obstacles?

    <p>Reentry Circuit</p> Signup and view all the answers

    Which class of antiarrhythmic drugs primarily works by sodium channel blockade?

    <p>Class I</p> Signup and view all the answers

    Which of the following is not a common trigger for arrhythmia?

    <p>Hyperglycemia</p> Signup and view all the answers

    What is the primary effect of Procainamide?

    <p>Slows conduction velocity</p> Signup and view all the answers

    Which of the following is a side effect of Quinidine?

    <p>Cinchonism</p> Signup and view all the answers

    What type of tachycardia is defined as having a heart rate of 180 bpm or more?

    <p>Supraventricular Tachycardia</p> Signup and view all the answers

    What is the pharmacological aim when treating arrhythmias?

    <p>To reduce ectopic pacemaker activity</p> Signup and view all the answers

    Which arrhythmia is characterized by a gradual change in the amplitude and twisting of the QRS complexes?

    <p>Torsades de Pointes</p> Signup and view all the answers

    What is the significance of calcium channel blockade in antiarrhythmic therapy?

    <p>Decreases automaticity</p> Signup and view all the answers

    Which adverse effect is associated with disopyramide?

    <p>Urinary retention</p> Signup and view all the answers

    What is a characteristic of class IB antiarrhythmic agents?

    <p>They shorten the action potential.</p> Signup and view all the answers

    Which class of antiarrhythmic drugs is primarily used for atrial arrhythmias?

    <p>Class II</p> Signup and view all the answers

    What is the mechanism of toxicity in Flecainide?

    <p>Proarrhythmic effects</p> Signup and view all the answers

    Which statement about Amiodarone is false?

    <p>It primarily treats supraventricular arrhythmias.</p> Signup and view all the answers

    What effect does Dronedarone lack compared to Amiodarone?

    <p>Iodine atoms</p> Signup and view all the answers

    Which antiarrhythmic drug is indicated for the maintenance of normal sinus rhythm in atrial fibrillation?

    <p>Dofetilide</p> Signup and view all the answers

    Which class of drugs does Verapamil belong to?

    <p>Class IV</p> Signup and view all the answers

    What is a common side effect of Sotalol?

    <p>Torsades de pointes</p> Signup and view all the answers

    Which antiarrhythmic drug is effective in relieving chronic pain due to diabetic neuropathy?

    <p>Mexiletine</p> Signup and view all the answers

    Study Notes

    Heart Conduction

    • Heart conduction involves four steps
      • Pacemaker impulse generation
      • AV node impulse conduction
      • AV bundle impulse conduction
      • Purkinje fibers impulse conduction

    Action Potential Phases

    • 0 = Upstroke/Depolarization
    • 1 = Early Fast Repolarization
    • 2 = Plateau
    • 3 = Repolarization
    • 4 = Diastole

    ECG

    • The ECG reflects the depolarization and repolarization waves of the heart

    Normal ECG

    • P wave: generated by atrial depolarization
    • QRS wave: generated by ventricular muscle depolarization
    • T wave: generated by ventricular repolarization

    Arrhythmia

    • Also known as dysrrhythmia
    • Describes irregular heartbeats
      • Tachycardia: heart beats too fast
      • Bradycardia: heart beats too slowly
      • Premature contraction: heart beats too early
      • Fibrillation: heart beats irregularly

    Factors that trigger arrhythmia

    • Ischemia
    • Hypoxia
    • Acidosis or Alkalosis
    • Electrolyte Abnormalities
    • Excessive catecholamine exposure
    • Autonomic influences
    • Drug toxicity (e.g., Digitalis)
    • Overstretching of cardiac fibers
    • Presence of scarred/diseased tissues

    Causes of Arrhythmia

    • Abnormal automaticity
    • Disturbances in impulse conduction

    Abnormal Automaticity

    • Hypokalemia
    • Beta-Adrenoceptor Stimulation
    • Positive Chronotropic Drugs
    • Fiber Stretch
    • Acidosis

    Disturbances in Impulse Conduction

    • AV nodal block
    • Bundle Branch Block

    Reentry or "Circus Movement"

    • Requires three conditions:
      • Presence of obstacle (anatomic or physiologic)
      • Unidirectional block at some point in the circuit; conduction must die out in one direction
      • Conduction time around the circuit must be long enough that the retrograde impulse does not enter refractory tissue as it travels around the obstacle

    Atrial Fibrillation (AFib)

    • No visible P waves
    • Irregular R-R intervals

    Problems with AFib

    • Anxiety
    • Palpitations
    • Risk of heart failure symptoms
    • Risk of cardiac thrombus & embolism (stroke)

    Supraventricular Tachycardia (SVT)

    • Heart rate ≥ 180 bpm

    Ventricular Tachycardia (VT)

    • Monomorphic
    • Polymorphic (e.g., Torsades de Pointes)

    Basic Pharmacology of Antiarrhythmic Agents

    Aim of Therapy

    • Reduce ectopic pacemaker activity
    • Modify conduction or refractoriness in reentry circuits to disable "circus movement"

    Major Mechanisms of Action

    • Sodium channel blockade
    • Blockade of sympathetic autonomic effects in the heart
    • Prolongation of the effective refractory period
    • Calcium channel blockade

    Specific Antiarrhythmic Agents

    Class I: Sodium Channel Blockers

    Class IA

    • Prolongs the action potential
      • Procainamide
      • Quinidine
      • Disopyramide
    Procainamide
    • Slows conduction velocity and pacemaker rate
    • Prolongs action potential duration
    • Dissociates from sodium channel with intermediate kinetics
    • Direct depressant effects on SA and AV nodes
    Clinical Applications:
    • Most atrial and ventricular arrhythmias
    • Second-line drug for most sustained ventricular arrhythmias associated with acute MI
    Procainamide Toxicity
    • Hypotension
    • QT interval prolongation
    • Induction of Torsade de Pointes
    • Long-term therapy produces reversible lupus-related symptoms
    Quinidine
    • Similar to Procainamide but more toxic
    Quinidine Toxicity
    • Torsade de Pointes
    • Cinchonism (headache, dizziness, and tinnitus)

    Class IB

    • Shortens action potential
      • Lidocaine
      • Phenytoin
      • Tocainide
      • Mexiletine
    Lidocaine
    • Xylocaine®
    • Low incidence of toxicity and high effectiveness against arrhythmias during myocardial infarction
    • Given intravenously
    Clinical Applications
    • Terminate ventricular tachycardia
    • Prevent ventricular fibrillation after cardioversion
    Lidocaine Toxicity
    • Neurologic symptoms: Nystagmus, paresthesia, tremor, nausea, lightheadedness, hearing disturbances, slurred speech, convulsions
    Mexiletine
    • Mexitil®
    • Orally active congener of Lidocaine
    Clinical Applications
    • Similar to Lidocaine
    • Significant efficacy in relieving chronic pain (especially diabetic neuropathy and nerve injury)
    Mexiletine Toxicity
    • Neurologic: Tremor, blurred vision, lethargy

    Class IC

    • No effect on action potential
      • Flecainide
      • Encainide
      • Moricizine
      • Propafenone
    Flecainide
    • Tambocor®
    • Potent blocker of sodium and potassium channels with slow unblocking kinetics
    Clinical Applications
    • Supraventricular Arrhythmias in patients with normal hearts
    • DO NOT USE in ischemic conditions (Post-Myocardial Infarction)
    Flecainide Toxicity
    • Proarrhythmic
    Propafenone
    • Rhythmol®
    • Primarily used for supraventricular arrhythmias
    • Adverse Drug Reactions (ADRs): Metallic taste, constipation, arrhythmia exacerbation
    Moricizine
    • Phenothiazine derivative used for the treatment of ventricular arrhythmias

    Class II: Beta-Adrenoceptor Blocking Agents

    • Clinical Applications
      • Atrial arrhythmias
      • Prevention of recurrent infarction and sudden death

    Class II Toxicity

    • Asthma

    • AV Blockade

    • Acute Heart Failure

    • Propanolol (Inderal®)

    • Esmolol (Brevibloc®) - a short-acting β-blocker, primarily used as an antiarrhythmic drug for intraoperative and other acute arrhythmias

    • Sotalol - non-selective β-blocking drug that prolongs the action potential

    Class III: Drugs that Prolong Effective Refractory Period by Prolonging Action Potential: Potassium Channel Blockers

    • Amiodarone
    • Sotalol
    • Bretylium
    • Dofetilide
    • Ibutilide
    Amiodarone
    • Cordarone
    • Given IV or PO
    Clinical Applications
    • Serious ventricular arrhythmias
    • Supraventricular arrhythmias
    Amiodarone Toxicity
    • Bradycardia
    • Heart block in diseased hearts
    • Peripheral vasodilation
    • Pulmonary & hepatic toxicity
    • Hyper- or hypothyroidism
    • Photodermatitis
      • Gray-blue discoloration in exposed areas of the skin
    • Asymptomatic corneal microdeposits
    • Blocks the peripheral conversion of thyroxine (T4) and triiodothyronine (T3)
    • Potential source of large amounts of inorganic iodine
    Dronedaron
    • Structural analog of Amiodarone but lacks iodine atoms
    • First antiarrhythmic drug shown to reduce mortality or hospitalization in patients with atrial fibrillation
    Vernakalant
    • Investigational multichannel blocker developed for the treatment of atrial fibrillation
    Vernakalant Toxicity
    • Dysgeusia (disturbance of taste)
    • Sneezing
    • Paresthesia
    • Cough
    • Hypotension
    Sotalol
    • Betapace®
    • Has both β-adrenergic blocking (Class II) and action potential-prolonging actions (Class III)
    Dofetilide
    • Tikosyn
    • Approved for the maintenance of normal sinus rhythm in patients with atrial fibrillation
    • S/E: Torsades de Pointes
    Ibutilide
    • Corvert®
    • IV is used for the acute conversion of atrial flutter and atrial fibrillation to normal sinus rhythm
    • S/E: Torsades de Pointes, QT interval prolongation

    Class IV: Calcium Channel Blocking Drugs

    • Verapamil - prototype
      • First introduced as antianginal agents
    • Dihydropyridines do not share antiarrhythmic efficacy and may precipitate arrhythmias
    Verapamil
    • Isoptin®
    • Blocks both activated and inactivated L-type calcium channels
    Effects
    • Slows SA node automaticity and AV nodal conduction velocity
    • Decreases cardiac contractility
    • Reduces blood pressure
    Clinical Applications
    • Supraventricular tachycardia
    Diltiazem
    • Cardizem®
    • Similar efficacy to verapamil in the management of supraventricular arrhythmias, including rate control in atrial fibrillation

    Miscellaneous Antiarrhythmic Agents

    Digoxin
    • MOA: Inhibits Na+/K+-ATPase
    • Uses:
      • 1-2 ng/mL (for atrial fibrillation or flutter)
      • 0.5-0.8 ng/mL (for systolic heart failure)
    Adenosine
    • Adenocard®
    • Nucleoside that occurs naturally throughout the body
    • Half-life: < 10 seconds
    Mechanism of Action
    • Activation of inward rectifier K+ current and inhibition of Ca2+ current
    Clinical Applications
    • Currently, the drug of choice (DOC) for paroxysmal supraventricular tachycardia
    Adenosine Toxicity
    • Flushing
    • Chest tightness
    • Dizziness
    Magnesium
    • MOA: Poorly understood; interacts with Na+/K+ ATPase, K+, and Ca2+ channels
    Clinical Applications
    • Torsades de Pointes
    • Digitalis-induced arrhythmias
    Magnesium Toxicity
    • Muscle weakness with overdose
    Potassium
    • MOA: Increases K+ permeability, K+ current
    Effects of Increasing K+ Serum
    • A resting potential depolarizing action
    • A membrane potential stabilizing action
    • Slows ectopic pacemakers
    • Slows conduction velocity in the heart
    Clinical Applications
    • Digitalis-induced arrhythmias
    • Arrhythmias associated with hypokalemia
    Potassium Toxicity
    • Reentrant arrhythmias
    • Fibrillation
    • Cardiac arrest with overdose

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Test your understanding of heart conduction, action potential phases, and electrocardiogram (ECG) interpretation. This quiz covers important concepts such as normal ECG waves and arrhythmias, along with their triggers. Enhance your knowledge of cardiovascular physiology through these essential topics.

    More Like This

    Interpreting ECG: Heart Rate and Rhythm
    25 questions
    Electrocardiogram (ECG) Basics
    10 questions
    lab 6 - ECG
    24 questions

    lab 6 - ECG

    WorldFamousJasper2150 avatar
    WorldFamousJasper2150
    Use Quizgecko on...
    Browser
    Browser